Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Bought by First Trust Direct Indexing L.P.

First Trust Direct Indexing L.P. increased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 7.0% in the 1st quarter, HoldingsChannel reports. The institutional investor owned 10,288 shares of the medical equipment provider’s stock after acquiring an additional 669 shares during the period. First Trust Direct Indexing L.P.’s holdings in Intuitive Surgical were worth $4,106,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in the business. Baystate Wealth Management LLC increased its holdings in shares of Intuitive Surgical by 150.0% in the fourth quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 45 shares in the last quarter. MCF Advisors LLC raised its position in Intuitive Surgical by 108.1% during the fourth quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock valued at $26,000 after buying an additional 40 shares during the period. Able Wealth Management LLC purchased a new stake in Intuitive Surgical in the 4th quarter worth about $28,000. Atticus Wealth Management LLC boosted its position in Intuitive Surgical by 85.4% during the 4th quarter. Atticus Wealth Management LLC now owns 89 shares of the medical equipment provider’s stock worth $30,000 after acquiring an additional 41 shares during the period. Finally, MeadowBrook Investment Advisors LLC purchased a new position in Intuitive Surgical during the 4th quarter valued at about $30,000. Institutional investors own 83.64% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages recently commented on ISRG. BTIG Research boosted their price objective on shares of Intuitive Surgical from $412.00 to $421.00 and gave the company a “buy” rating in a research report on Friday, April 19th. The Goldman Sachs Group began coverage on shares of Intuitive Surgical in a research note on Thursday, May 30th. They issued a “buy” rating and a $500.00 target price for the company. Jefferies Financial Group increased their price target on shares of Intuitive Surgical from $365.00 to $375.00 and gave the stock a “hold” rating in a research note on Friday, April 19th. Stifel Nicolaus increased their target price on shares of Intuitive Surgical from $420.00 to $430.00 and gave the stock a “buy” rating in a research report on Monday, April 8th. Finally, Robert W. Baird reduced their price target on Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating for the company in a research report on Friday, April 19th. Six investment analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. According to MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average price target of $404.79.

Intuitive Surgical Stock Performance

NASDAQ:ISRG traded down $4.00 on Thursday, hitting $434.81. 826,374 shares of the stock were exchanged, compared to its average volume of 1,473,994. Intuitive Surgical, Inc. has a 52 week low of $254.85 and a 52 week high of $448.10. The stock has a market capitalization of $154.23 billion, a price-to-earnings ratio of 78.49, a P/E/G ratio of 5.67 and a beta of 1.39. The company’s 50-day moving average price is $407.60 and its 200 day moving average price is $385.43.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.40 by $0.10. The firm had revenue of $1.89 billion for the quarter, compared to analysts’ expectations of $1.87 billion. Intuitive Surgical had a net margin of 27.16% and a return on equity of 12.91%. The business’s revenue for the quarter was up 11.5% on a year-over-year basis. During the same period last year, the firm earned $1.00 earnings per share. As a group, equities research analysts predict that Intuitive Surgical, Inc. will post 4.8 earnings per share for the current year.

Insider Buying and Selling at Intuitive Surgical

In other news, Director Craig H. Barratt sold 1,400 shares of Intuitive Surgical stock in a transaction on Wednesday, June 12th. The shares were sold at an average price of $421.06, for a total transaction of $589,484.00. The sale was disclosed in a legal filing with the SEC, which is available through this link. In other Intuitive Surgical news, Director Craig H. Barratt sold 1,400 shares of the firm’s stock in a transaction that occurred on Wednesday, June 12th. The shares were sold at an average price of $421.06, for a total transaction of $589,484.00. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Alan J. Levy sold 2,000 shares of the company’s stock in a transaction that occurred on Tuesday, April 23rd. The shares were sold at an average price of $370.70, for a total transaction of $741,400.00. Following the completion of the transaction, the director now owns 25,319 shares of the company’s stock, valued at approximately $9,385,753.30. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 17,956 shares of company stock valued at $6,927,011. 0.80% of the stock is currently owned by company insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.